AMN Healthcare forecasts Q3 2026 adjusted EBITDA margin 6.5%-7%
AMN•Q3 2026 guidance
AMN Healthcare issued Q3 2026 guidance for adjusted EBITDA margin of about 6.5% to 7%.
Guidance implies operating margin of about 0.2% to 0.8%, and depreciation and amortization of about 4.9% to 5%.
The bridge to adjusted EBITDA margin includes share-based compensation of about 1.1%, and integration and other costs of about 0.2%.
